Cancer Treatment Centers of America Teams Up to Raise Prostate Cancer Awareness

African-American men have the highest rate of prostate cancer. This fact along with the fact that prostate cancer is the most common cancer for men has put the Cancer Treatment Centers of America, National Football League Alumni Association (NFLA) and LabCorp to work. The organization has teamed up with the to get men educated about the cancer that effects almost one in seven men.

The American Cancer Society predicts that in 2017 there will be over 160,000 new prostate cancer diagnoses. The three organizations offered free Prostate Specific Antigen screenings from September 1 to October 15 to 2,000 men who are ages 40 and older. The screening was performed by LabCorp at any of its 1,750 locations throughout the United States. After the 2,000 spots were taken, qualifying men could set up a schedule for $25.

This campaign could help men who are at higher risk for the disease to become more knowledgeable. Men at greater risk are usually those that are African-American and have a family history with disease. They recommended that these men get tested starting at the age of 40.

In addition, NFL head coaches Herm Edwards, Dick Vermeil, and Bill Cowher also helped raise awareness by giving public service announcements a part of the Prostate Pep Talk. As Prostate Awareness Month was September the public service announcements were set to air throughout the month.

The campaign kick-off press conference was held on August 30th at NFL Films in New Jersey. The event included players from the NFL. Cancer Treatment Centers of America hospitals across the U.S. also participated in campaign events.

Cancer Treatment Centers of America is headquartered in Boca Raton, Florida and is a network of five hospitals across the nation. The centers treat adult patients who are battling cancer. Hospitals sit in the cities of Atlanta, Chicago, Philadelphia, Phoenix and Tulsa.

CTCA is committed to keeping patients at the core of their work. Their approach gives patients access to advanced treatment, such as, surgery, radiation, therapies and more.